Development and Validation of HER3 and Phospho-HER3 Immunohistochemistry for Patient Stratification

机译：HER3和磷脂-HER3免疫组织化学对患者分层的开发与验证

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Immunohistochemistry (IHC) provides information of high prognostic and predictive value for patients. For the analysis of clinical samples, IHC needs to be validated according to guidelines for the validation of analytical methods (ICH, FDA and EMA) even though a direct measurement of target concentrations is not possible.

机译：免疫组织化学（IHC）为患者提供了高预后和预测值的信息。对于临床样本的分析，即使无法进行目标浓度的直接测量，也需要根据分析方法（ICH，FDA和EMA）的验证指南来验证IHC。

著录项

来源
《International Molecular Medicine Tri-Conference.》|2015年||共1页
会议地点
作者
Philipp C. Uhlig; Caroline Weber; Stefanie Geipel; Anne-Kathrin Possogel; Jasmin von Erichsen; Hartmut Juhl; Kerstin A. David;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类 R393;
关键词

相似文献

外文文献
中文文献
专利

1. Phosphorylated HER3 and FITC-labeled trastuzumab immunohistochemistry in patients with HER2-positive breast cancer treated with adjuvant trastuzumab [J] . Naoki Kanomata, Junichi Kurebayashi, Takuya Moriya Medical electron microscopy . 2019,第2期

机译：辅助曲妥珠单抗治疗HER2阳性乳腺癌患者的磷酸化HER3和FITC标记的曲妥珠单抗免疫组织化学
2. Phosphorylated HER3 and FITC-labeled trastuzumab immunohistochemistry in patients with HER2-positive breast cancer treated with adjuvant trastuzumab [J] . Naoki Kanomata, Junichi Kurebayashi, Takuya Moriya Medical electron microscopy . 2019,第2期

机译：用佐剂曲妥珠单抗治疗的Her2阳性乳腺癌患者磷酸化HER3和FITC标记的曲妥珠单抗免疫组化
3. HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients [J] . BaeS.Y., LaChoiY., KimS., Breast cancer research and treatment. . 2013,第3期

机译：免疫组织化学检测到的HER3状况与激素受体阴性乳腺癌患者的不良预后相关
4. Development and Validation of HER3 and Phospho-HER3 Immunohistochemistry for Patient Stratification [C] . Philipp C. Uhlig, Caroline Weber, Stefanie Geipel, International Molecular Medicine Tri-Conference. . 2015

机译：HER3和磷脂-HER3免疫组织化学对患者分层的开发与验证
5. Examination of prognostic clinical parameters, with development and validation of two models for stratification of illness severity in canine and feline ICU patients [D] . Hayes, Galina Merete 2010

机译：检查预后临床参数，并开发和验证两种用于对犬和猫ICU患者的疾病严重程度进行分层的模型
6. Development and validation of a risk stratification model for predicting the mortality of acute kidney injury in critical care patients [O] . Haofan Huang, Yong Liu, Ming Wu, 2021

机译：预测急性护理患者急性肾损伤死亡率风险分层模型的开发与验证
7. POS1104 THE DEVELOPMENT AND VALIDATION OF A RISK STRATIFICATION QUESTIONNAIRE TO SCREEN FOR MEDICATION RELATED OSTEONECROSIS OF THE JAW RISK IN OSTEOPOROTIC PATIENTS [O] . Y. El-Miedany, M. El Gaafary, M. Toth, 2021

机译：POS1104骨质疏松患者颌骨颌骨瘤筛选风险分层问卷的开发和验证

Development and Validation of HER3 and Phospho-HER3 Immunohistochemistry for Patient Stratification

摘要

著录项

相似文献

相关主题

期刊订阅